Literature DB >> 25319978

Low frequency of HNPCC-associated microsatellite instability and aberrant MMR protein expression in early-onset bladder cancer.

Johannes Giedl1, Roland Schneckenpointner2, Thomas Filbeck3, Petra Ruemmele4, Ferdinand Hofstaedter4, Maximilian Burger5, Arndt Hartmann1, Robert Stoehr6.   

Abstract

OBJECTIVES: Recently, it was shown that patients with Lynch syndrome due to an MSH2 mutation are at increased risk for the development of bladder cancer. To further this discussion, we screened the largest investigated cohort of patients with early-onset bladder cancer for microsatellite instability (MSI) and mismatch repair (MMR) deficiency to determine a possible role of Lynch syndrome in young patients with bladder cancer.
METHODS: A total of 109 cases of bladder tumors from young patients (aged <45 years) were examined for MSI (Bethesda consensus panel). Expression of MMR proteins (hMLH1, hMSH2, and hMSH6) was evaluated by immunohistochemistry using a tissue microarray. Results were compared with a series of unselected consecutive bladder tumors (n = 95).
RESULTS: Regarding the frequency of MSI high (1% vs 0%) or abnormal expression of MMR proteins (2% vs 6.5%), no significant difference between the early-onset and unselected patient group was found.
CONCLUSIONS: In young patients with bladder tumors, MSI and defects in MMR protein expression were not more frequent than in a series of consecutive bladder tumors. Most bladder tumors in young patients are not to be attributed to Lynch syndrome. Copyright© by the American Society for Clinical Pathology.

Entities:  

Keywords:  Bladder cancer; Early onset; Lynch syndrome; Microsatellite instability

Mesh:

Substances:

Year:  2014        PMID: 25319978     DOI: 10.1309/AJCPVTCJ4VU5HKVZ

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  8 in total

Review 1.  Familial/inherited cancer syndrome: a focus on the highly consanguineous Arab population.

Authors:  Fawz S AlHarthi; Alya Qari; Alaa Edress; Malak Abedalthagafi
Journal:  NPJ Genom Med       Date:  2020-02-03       Impact factor: 8.617

2.  Identification of Lynch syndrome-associated DNA mismatch repair-deficient bladder cancer in a Japanese hospital-based population.

Authors:  Makoto Kagawa; Satoru Kawakami; Azusa Yamamoto; Okihide Suzuki; Nao Kamae; Hidetaka Eguchi; Yasushi Okazaki; Gou Yamamoto; Kiwamu Akagi; Jun-Ichi Tamaru; Tatsuro Yamaguchi; Tomio Arai; Hideyuki Ishida
Journal:  Int J Clin Oncol       Date:  2021-07-02       Impact factor: 3.402

3.  Clinical significance of chromodomain helicase/ATPase DNA binding protein 1-like and human mutL homolog 1 gene expression in cholangiocarcinoma.

Authors:  Jingwen Hua; Shiniao Li; Changwen Huang
Journal:  Oncol Lett       Date:  2018-06-28       Impact factor: 2.967

4.  Inverted urothelial papilloma of the upper urinary tract: description of two cases with systematic literature review.

Authors:  R Santi; I C Galli; V Canzonieri; J I Lopez; G Nesi
Journal:  Diagn Pathol       Date:  2020-04-22       Impact factor: 2.644

Review 5.  Familial/inherited cancer syndrome: a focus on the highly consanguineous Arab population.

Authors:  Fawz S AlHarthi; Alya Qari; Alaa Edress; Malak Abedalthagafi
Journal:  NPJ Genom Med       Date:  2020-02-03       Impact factor: 8.617

Review 6.  How Should We Test for Lynch Syndrome? A Review of Current Guidelines and Future Strategies.

Authors:  Richard Gallon; Peter Gawthorpe; Rachel L Phelps; Christine Hayes; Gillian M Borthwick; Mauro Santibanez-Koref; Michael S Jackson; John Burn
Journal:  Cancers (Basel)       Date:  2021-01-22       Impact factor: 6.639

7.  CD8 lymphocytes in tumors and nonsynonymous mutational load correlate with prognosis of bladder cancer patients treated with immune checkpoint inhibitors.

Authors:  Boya Deng; Jae-Hyun Park; Lili Ren; Poh Yin Yew; Kazuma Kiyotani; Tatjana Antic; Kelly O'Connor; Peter H O'Donnell; Yusuke Nakamura
Journal:  Cancer Rep (Hoboken)       Date:  2018-04-10

8.  Immunohistochemical evaluation of mismatch repair proteins and p53 expression in extrauterine carcinosarcoma/sarcomatoid carcinoma.

Authors:  Michał Kunc; Anna Gabrych; Bartłomiej Rękawiecki; Adam Gorczyński; Johannes Haybaeck; Wojciech Biernat; Piotr Czapiewski
Journal:  Contemp Oncol (Pozn)       Date:  2020-03-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.